Cadema Corp said entered letter intent national underwriting firm offering five mln dlrs worth convertible preferred stock .
Cadema said file registration statement Securities Exchange Commission later month offering .
Proceeds used fund clinical trial company 's treatment rheumatoid arthritis metastatic bone cancer .
It also said increased size board six five member .
Reuter & # 3 ; 